Manipulation of the ubiquitin-proteasome pathway by small DNA tumor viruses

Virology

Volumn 384, Issue 2, 2009, Pages 317-323

  Blanchette, Paola ^a   Branton, Philip E ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

E3 ligase; Small DNA tumor viruses; Ubiquitin proteasome pathway

Indexed keywords

ADENOVIRUS PROTEIN E4; CELL PROTEIN; E1B PROTEIN; PROTEIN E6; PROTEIN E7; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN; VIRUS PROTEIN;

CELL CYCLE; DNA TUMOR VIRUS; ENZYME SPECIFICITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 6; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40;

DNA TUMOR VIRUSES; ONCOGENE PROTEINS, VIRAL; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; VIRUS REPLICATION;

EID: 59349088768     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.10.005     Document Type: Short Survey

References (141)

1. Ali S.H., Kasper J.S., Arai T., and DeCaprio J.A. Cul7/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation. J. Virol. 78 6 (2004) 2749-2757
2. Baker A., Rohleder K.J., Hanakahi L.A., and Ketner G. Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation. J. Virol. 81 13 (2007) 7034-7040
3. Band V., De Caprio J.A., Delmolino L., Kulesa V., and Sager R. Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells. J. Virol. 65 12 (1991) 6671-6676
4. Baseman J.G., and Koutsky L.A. The epidemiology of human papillomavirus infections. J. Clin. Virol. 32 Suppl 1 (2005) S16-S24
5. Bellanger S., Demeret C., Goyat S., and Thierry F. Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J. Virol. 75 16 (2001) 7244-7251
6. Bellanger S., Blachon S., Mechali F., Bonne-Andrea C., and Thierry F. High-risk but not low-risk HPV E2 proteins bind to the APC activators Cdh1 and Cdc20 and cause genomic instability. Cell Cycle 4 11 (2005) 1608-1615
7. Berezutskaya E., Yu B., Morozov A., Raychaudhuri P., and Bagchi S. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein. Cell Growth Differ. 8 12 (1997) 1277-1286
8. Bernassola F., Karin M., Ciechanover A., and Melino G. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 14 1 (2008) 10-21
9. Blanchette P., Cheng C.Y., Yan Q., Ketner G., Ornelles D.A., Dobner T., Conaway R.C., Conaway J.W., and Branton P.E. Both BC-box motifs of adenovirus protein E4orf6 are required to efficiently assemble an E3 ligase complex that degrades p53. Mol. Cell. Biol. 24 21 (2004) 9619-9629
10. Blumenfeld N., Gonen H., Mayer A., Smith C.E., Siegel N.R., Schwartz A.L., and Ciechanover A. Purification and characterization of a novel species of ubiquitin-carrier protein, E2, that is involved in degradation of non-"N-end rule" protein substrates. J. Biol. Chem. 269 13 (1994) 9574-9581
11. Bosu D.R., and Kipreos E.T. Cullin-RING ubiquitin ligases: global regulation and activation cycles. Cell Div. 3 (2008) 7
12. Bouvard V., Matlashewski G., Gu Z.M., Storey A., and Banks L. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology 203 1 (1994) 73-80
13. Boyer S.N., Wazer D.E., and Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56 20 (1996) 4620-4624
14. Braithwaite A., Nelson C., Skulimowski A., McGovern J., Pigott D., and Jenkins J. Transactivation of the p53 oncogene by E1a gene products. Virology 177 2 (1990) 595-605
15. Camus S., Higgins M., Lane D.P., and Lain S. Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6. FEBS Lett. 536 1-3 (2003) 220-224
16. Camus S., Menendez S., Cheok C.F., Stevenson L.F., Lain S., and Lane D.P. Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6. Oncogene 26 28 (2007) 4059-4070
17. Cathomen T., Collete D., and Weitzman M.D. A chimeric protein containing the N terminus of the adeno-associated virus Rep protein recognizes its target site in an in vivo assay. J. Virol. 74 5 (2000) 2372-2382
18. Cheng C.Y., Blanchette P., and Branton P.E. The adenovirus E4orf6 E3 ubiquitin ligase complex assembles in a novel fashion. Virology 364 1 (2007) 36-44
19. Ciechanover A., Shkedy D., Oren M., and Bercovich B. Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2. J. Biol. Chem. 269 13 (1994) 9582-9589
20. Daling J.R., Madeleine M.M., Schwartz S.M., Shera K.A., Carter J.J., McKnight B., Porter P.L., Galloway D.A., McDougall J.K., and Tamimi H. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol. Oncol. 84 2 (2002) 263-270
21. Duan D.R., Pause A., Burgess W.H., Aso T., Chen D.Y., Garrett K.P., Conaway R.C., Conaway J.W., Linehan W.M., and Klausner R.D. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269 5229 (1995) 1402-1406
22. Fang S., Jensen J.P., Ludwig R.L., Vousden K.H., and Weissman A.M. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275 12 (2000) 8945-8951
23. Favre-Bonvin A., Reynaud C., Kretz-Remy C., and Jalinot P. Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome. J. Virol. 79 7 (2005) 4229-4237
24. Fournier N., Raj K., Saudan P., Utzig S., Sahli R., Simanis V., and Beard P. Expression of human papillomavirus 16 E2 protein in Schizosaccharomyces pombe delays the initiation of mitosis. Oncogene 18 27 (1999) 4015-4021
25. Fukazawa T., Miyake S., Band V., and Band H. Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins. J. Biol. Chem. 271 24 (1996) 14554-14559
26. Gao Q., Srinivasan S., Boyer S.N., Wazer D.E., and Band V. The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation. Mol. Cell. Biol. 19 1 (1999) 733-744
27. Gao Q., Kumar A., Singh L., Huibregtse J.M., Beaudenon S., Srinivasan S., Wazer D.E., Band H., and Band V. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. Cancer Res. 62 11 (2002) 3315-3321
28. Gardiol D., Kuhne C., Glaunsinger B., Lee S.S., Javier R., and Banks L. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18 40 (1999) 5487-5496
29. Gewin L., Myers H., Kiyono T., and Galloway D.A. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev. 18 18 (2004) 2269-2282
30. Gillison M.L., and Lowy D.R. A causal role for human papillomavirus in head and neck cancer. Lancet 363 9420 (2004) 1488-1489
31. Glaunsinger B.A., Lee S.S., Thomas M., Banks L., and Javier R. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19 46 (2000) 5270-5280
32. Graham F.L., Smiley J., Russell W.C., and Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36 1 (1977) 59-74
33. Grm H.S., and Banks L. Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent. J. Gen. Virol. 85 Pt 10 (2004) 2815-2819
34. Gross-Mesilaty S., Reinstein E., Bercovich B., Tobias K.E., Schwartz A.L., Kahana C., and Ciechanover A. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc. Natl. Acad. Sci. U. S. A. 95 14 (1998) 8058-8063
35. Gupta-Rossi N., Le Bail O., Gonen H., Brou C., Logeat F., Six E., Ciechanover A., and Israel A. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J. Biol. Chem. 276 37 (2001) 34371-34378
36. Handa K., Yugawa T., Narisawa-Saito M., Ohno S., Fujita M., and Kiyono T. E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein. J. Virol. 81 3 (2007) 1379-1389
37. Harada J.N., Shevchenko A., Pallas D.C., and Berk A.J. Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J. Virol. 76 18 (2002) 9194-9206
38. Harada N., Maniwa Y., Yoshimura M., Nagata M., Hamada H., Yokono K., and Okita Y. E1B-deleted adenovirus replicates in p53-deficient lung cancer cells due to the absence of apoptosis. Oncol. Rep. 14 5 (2005) 1155-1163
39. Hatakeyama S., Jensen J.P., and Weissman A.M. Subcellular localization and ubiquitin-conjugating enzyme (E2) interactions of mammalian HECT family ubiquitin protein ligases. J. Biol. Chem. 272 24 (1997) 15085-15092
40. Hohlweg U., Dorn A., Hosel M., Webb D., Buettner R., and Doerfler W. Tumorigenesis by adenovirus type 12 in newborn Syrian hamsters. Curr. Top. Microbiol. Immunol. 273 (2004) 215-244
41. Honda R., and Yasuda H. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 19 11 (2000) 1473-1476
42. Honda R., Tanaka H., and Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420 1 (1997) 25-27
43. Huh K., Zhou X., Hayakawa H., Cho J.Y., Libermann T.A., Jin J., Harper J.W., and Munger K. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J. Virol. 81 18 (2007) 9737-9747
44. Huibregtse J.M., Scheffner M., and Howley P.M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10 13 (1991) 4129-4135
45. Huibregtse J.M., Scheffner M., Beaudenon S., and Howley P.M. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. U. S. A. 92 7 (1995) 2563-2567
46. Hwang E.S., Nottoli T., and Dimaio D. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology 211 1 (1995) 227-233
47. Jeong K.W., Kim H.Z., Kim S., Kim Y.S., and Choe J. Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation. Oncogene 26 4 (2007) 487-499
48. Jin J., Cardozo T., Lovering R.C., Elledge S.J., Pagano M., and Harper J.W. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev. 18 21 (2004) 2573-2580
49. Jing M., Bohl J., Brimer N., Kinter M., and Vande Pol S.B. Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins. J. Virol. 81 5 (2007) 2231-2239
50. Joazeiro C.A., Wing S.S., Huang H., Leverson J.D., Hunter T., and Liu Y.C. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286 5438 (1999) 309-312
51. Jones D.L., and Munger K. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol. 71 4 (1997) 2905-2912
52. Kamio M., Yoshida T., Ogata H., Douchi T., Nagata Y., Inoue M., Hasegawa M., Yonemitsu Y., and Yoshimura A. SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein. Oncogene 23 17 (2004) 3107-3115
53. Kamura T., Burian D., Yan Q., Schmidt S.L., Lane W.S., Querido E., Branton P.E., Shilatifard A., Conaway R.C., and Conaway J.W. Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J. Biol. Chem. 276 32 (2001) 29748-29753
54. Kamura T., Maenaka K., Kotoshiba S., Matsumoto M., Kohda D., Conaway R.C., Conaway J.W., and Nakayama K.I. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev. 18 24 (2004) 3055-3065
55. Kasper J.S., Kuwabara H., Arai T., Ali S.H., and DeCaprio J.A. Simian virus 40 large T antigen's association with the CUL7 SCF complex contributes to cellular transformation. J. Virol. 79 18 (2005) 11685-11692
56. Kehmeier E., Ruhl H., Voland B., Stoppler M.C., Androphy E., and Stoppler H. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities. Virology 299 1 (2002) 72-87
57. Kiyono T., Hiraiwa A., Fujita M., Hayashi Y., Akiyama T., and Ishibashi M. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. U. S. A. 94 21 (1997) 11612-11616
58. Kleinberger T., and Shenk T. Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junB transcription. J. Virol. 67 12 (1993) 7556-7560
59. Koepp D.M., Schaefer L.K., Ye X., Keyomarsi K., Chu C., Harper J.W., and Elledge S.J. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294 5540 (2001) 173-177
60. Kohrman D.C., and Imperiale M.J. Simian virus 40 large T antigen stably complexes with a 185-kilodalton host protein. J. Virol. 66 3 (1992) 1752-1760
61. Kornitzer D., Sharf R., and Kleinberger T. Adenovirus E4orf4 protein induces PP2A-dependent growth arrest in Saccharomyces cerevisiae and interacts with the anaphase-promoting complex/cyclosome. J. Cell. Biol. 154 2 (2001) 331-344
62. Kosulin K., Haberler C., Hainfellner J.A., Amann G., Lang S., and Lion T. Investigation of adenovirus occurrence in pediatric tumor entities. J. Virol. 81 14 (2007) 7629-7635
63. Kuhne C., and Banks L. E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J. Biol. Chem. 273 51 (1998) 34302-34309
64. Lee S.S., Weiss R.S., and Javier R.T. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. U. S. A. 94 13 (1997) 6670-6675
65. Lee S.S., Glaunsinger B., Mantovani F., Banks L., and Javier R.T. Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J. Virol. 74 20 (2000) 9680-9693
66. Leechanachai P., Banks L., Moreau F., and Matlashewski G. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 7 1 (1992) 19-25
67. Levkowitz G., Waterman H., Zamir E., Kam Z., Oved S., Langdon W.Y., Beguinot L., Geiger B., and Yarden Y. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12 23 (1998) 3663-3674
68. Li J., Pauley A.M., Myers R.L., Shuang R., Brashler J.R., Yan R., Buhl A.E., Ruble C., and Gurney M.E. SEL-10 interacts with presenilin 1, facilitates its ubiquitination, and alters A-beta peptide production. J. Neurochem. 82 6 (2002) 1540-1548
69. Li, S., Brignole, C., Marcellus, R.C., Thirlwell, S., Binda, O., McQuoid, M.J., Ashby, D., Chan, H., Zhang, Z., Miron, M.-J., Pallas, D.N., Branton, P.E., (submitted for publication).The adenovirus E4orf4 protein induces G2/M arrest and cel death by blocking PP2A phosphatase activity regulated by the B55 subunit. J. Virol.
70. Li, S., Szymborski, A., Miron, M.-J., Marcellus, R.C., Binda, O., Lavoie, J.N., Branton, P.E., (in press). The adenovirus E4or4 protein induces growth arrest and mitotic catastrophe in H1299 human lung carcinoma cells. Oncogene.
71. Li X., and Coffino P. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J. Virol. 70 7 (1996) 4509-4516
72. Lin C.H., Chang H.S., and Yu W.C. USP11 stabilizes HPV-16E7 and further modulates the E7 biological activity. J. Biol. Chem. 283 23 (2008) 15681-15688
73. Lowe S.W., and Ruley H.E. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7 4 (1993) 535-545
74. Luo K., Ehrlich E., Xiao Z., Zhang W., Ketner G., and Yu X.F. Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53. FASEB J. 21 8 (2007) 1742-1750
75. Malcles M.H., Cueille N., Mechali F., Coux O., and Bonne-Andrea C. Regulation of bovine papillomavirus replicative helicase e1 by the ubiquitin-proteasome pathway. J. Virol. 76 22 (2002) 11350-11358
76. Marcellus R.C., Chan H., Paquette D., Thirlwell S., Boivin D., and Branton P.E. Induction of p53-Independent apoptosis by the adenovirus E4orf4 protein requires binding to the Bα subunit of protein phosphatase 2A. J. Virol. 74 17 (2000) 7869-7877
77. Massimi P., Shai A., Lambert P., and Banks L. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Oncogene 27 12 (2008) 1800-1804
78. Mechali F., Hsu C.Y., Castro A., Lorca T., and Bonne-Andrea C. Bovine papillomavirus replicative helicase E1 is a target of the ubiquitin ligase APC. J. Virol. 78 5 (2004) 2615-2619
79. Moberg K.H., Bell D.W., Wahrer D.C., Haber D.A., and Hariharan I.K. Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 413 6853 (2001) 311-316
80. Moberg K.H., Mukherjee A., Veraksa A., Artavanis-Tsakonas S., and Hariharan I.K. The Drosophila F box protein archipelago regulates dMyc protein levels in vivo. Curr. Biol. 14 11 (2004) 965-974
81. Moore M., Horikoshi N., and Shenk T. Oncogenic potential of the adenovirus E4orf6 protein. Proc. Natl. Acad. Sci. U. S. A. 93 21 (1996) 11295-11301
82. Mui, M., Roopchand, D.M., Vogel, J., Branton, P.E., (submitted for publication). The adenovirus E4orf4 protein induces premature activation of APC(Cdc20) and mitotic arrest in Saccharomyces cerevisiae through a PP2A-dependent mechanism. Mol. Cell. Biol.
83. Nakagawa S., and Huibregtse J.M. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 20 21 (2000) 8244-8253
84. Nash P., Tang X., Orlicky S., Chen Q., Gertler F.B., Mendenhall M.D., Sicheri F., Pawson T., and Tyers M. Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 414 6863 (2001) 514-521
85. Nateri A.S., Riera-Sans L., Da Costa C., and Behrens A. The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science 303 5662 (2004) 1374-1378
86. Nayak R., Farris K.D., and Pintel D.J. E4Orf6-E1B-55k-dependent degradation of de novo-generated adeno-associated virus type 5 Rep52 and capsid proteins employs a cullin 5-containing E3 ligase complex. J. Virol. 82 7 (2008) 3803-3808
87. Nevels M., Rubenwolf S., Spruss T., Wolf H., and Dobner T. The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function. Proc. Natl. Acad. Sci. U. S. A. 94 4 (1997) 1206-1211
88. Nevels M., Rubenwolf S., Spruss T., Wolf H., and Dobner T. Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein. J. Virol. 74 11 (2000) 5168-5181
89. Nuber U., Schwarz S., Kaiser P., Schneider R., and Scheffner M. Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-F1) and characterization of their interaction with E6-AP and RSP5. J. Biol. Chem. 271 5 (1996) 2795-2800
90. Oh K.J., Kalinina A., Wang J., Nakayama K., Nakayama K.I., and Bagchi S. The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase. J. Virol. 78 10 (2004) 5338-5346
91. Pause A., Lee S., Worrell R.A., Chen D.Y., Burgess W.H., Linehan W.M., and Klausner R.D. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc. Natl. Acad. Sci. U. S. A. 94 6 (1997) 2156-2161
92. Pim D., and Banks L. HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6. Oncogene 18 52 (1999) 7403-7408
93. Pim D., Collins M., and Banks L. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7 1 (1992) 27-32
94. Pim D., Massimi P., and Banks L. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Oncogene 15 3 (1997) 257-264
95. Pim D., Thomas M., Javier R., Gardiol D., and Banks L. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene 19 6 (2000) 719-725
96. Poulin D.L., and DeCaprio J.A. Is there a role for SV40 in human cancer. J. Clin. Oncol. 24 26 (2006) 4356-4365
97. Querido E., Marcellus R.C., Lai A., Charbonneau R., Teodoro J.G., Ketner G., and Branton P.E. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71 5 (1997) 3788-3798
98. Querido E., Blanchette P., Yan Q., Kamura T., Morrison M., Boivin D., Kaelin W.G., Conaway R.C., Conaway J.W., and Branton P.E. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 15 23 (2001) 3104-3117
99. Querido E., Morrison M.R., Chu-Pham-Dang H., Thirlwell S.W., Boivin D., and Branton P.E. Identification of three functions of the adenovirus e4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex. J. Virol. 75 2 (2001) 699-709
100. Reinstein E., Scheffner M., Oren M., Ciechanover A., and Schwartz A. Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue. Oncogene 19 51 (2000) 5944-5950
101. Rodriguez M.S., Desterro J.M., Lain S., Lane D.P., and Hay R.T. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol. Cell. Biol. 20 22 (2000) 8458-8467
102. Roopchand D.E., Lee J.M., Shahinian S., Paquette D., Bussey H., and Branton P.E. Toxicity of human adenovirus E4orf4 protein in Saccharomyces cerevisiae results from interactions with the Cdc55 regulatory B subunit of PP2A. Oncogene 20 38 (2001) 5279-5290
103. Roth J., Konig C., Wienzek S., Weigel S., Ristea S., and Dobbelstein M. Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins. J. Virol. 72 11 (1998) 8510-8516
104. Rubin M.A., Kleter B., Zhou M., Ayala G., Cubilla A.L., Quint W.G., and Pirog E.C. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am. J. Pathol. 159 4 (2001) 1211-1218
105. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., and Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 6 (1990) 1129-1136
106. Scheffner M., Takahashi T., Huibregtse J.M., Minna J.D., and Howley P.M. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins. J. Virol. 66 8 (1992) 5100-5105
107. Scheffner M., Huibregtse J.M., Vierstra R.D., and Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75 3 (1993) 495-505
108. Scheffner M., Huibregtse J.M., and Howley P.M. Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc. Natl. Acad. Sci. U. S. A. 91 19 (1994) 8797-8801
109. Scheffner M., Nuber U., and Huibregtse J.M. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373 6509 (1995) 81-83
110. Schneider-Gadicke A., and Schwarz E. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5 9 (1986) 2285-2292
111. Schwartz R.A., Lakdawala S.S., Eshleman H.D., Russell M.R., Carson C.T., and Weitzman M.D. Distinct requirements of the adenovirus E1b55K protein for degradation of cellular substrates. J. Virol. 82 18 (2008) 9043-9055
112. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., and zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314 6006 (1985) 111-114
113. Sedman S.A., Barbosa M.S., Vass W.C., Hubbert N.L., Haas J.A., Lowy D.R., and Schiller J.T. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J. Virol. 65 9 (1991) 4860-4866
114. Selvey L.A., Dunn L.A., Tindle R.W., Park D.S., and Frazer I.H. Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines. J. Gen. Virol. 75 Pt 7 (1994) 1647-1653
115. Shein H.M., and Enders J.F. Transformation induced by simian virus 40 in human renal cell cultures. I. Morphology and growth characteristics. Proc. Natl. Acad. Sci. U. S. A. 48 (1962) 1164-1172
116. Shkedy D., Gonen H., Bercovich B., and Ciechanover A. Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system. FEBS Lett. 348 2 (1994) 126-130
117. Smotkin D., Prokoph H., and Wettstein F.O. Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J. Virol. 63 3 (1989) 1441-1447
118. Spanos W.C., Hoover A., Harris G.F., Wu S., Strand G.L., Anderson M.E., Klingelhutz A.J., Hendriks W., Bossler A.D., and Lee J.H. The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth. J. Virol. 82 5 (2008) 2493-2500
119. Spruck C.H., Strohmaier H., Sangfelt O., Muller H.M., Hubalek M., Muller-Holzner E., Marth C., Widschwendter M., and Reed S.I. hCDC4 gene mutations in endometrial cancer. Cancer Res. 62 16 (2002) 4535-4539
120. Steegenga W.T., Riteco N., Jochemsen A.G., Fallaux F.J., and Bos J.L. The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells. Oncogene 16 3 (1998) 349-357
121. Stewart D., Kazemi S., Li S., Massimi P., Banks L., Koromilas A.E., and Matlashewski G. Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18. J. Gen. Virol. 85 Pt 6 (2004) 1419-1426
122. Stewart D., Ghosh A., and Matlashewski G. Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53. J. Virol. 79 14 (2005) 8773-8783
123. Stoppler M.C., Straight S.W., Tsao G., Schlegel R., and McCance D.J. The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA. Virology 223 1 (1996) 251-254
124. Storrs C.H., and Silverstein S.J. PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6. J. Virol. 81 8 (2007) 4080-4090
125. Stracker T.H., Carson C.T., and Weitzman M.D. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418 6895 (2002) 348-352
126. Straight S.W., Hinkle P.M., Jewers R.J., and McCance D.J. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67 8 (1993) 4521-4532
127. Strohmaier H., Spruck C.H., Kaiser P., Won K.A., Sangfelt O., and Reed S.I. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413 6853 (2001) 316-322
128. Thomas M., and Banks L. Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 17 23 (1998) 2943-2954
129. Thomas M., Laura R., Hepner K., Guccione E., Sawyers C., Lasky L., and Banks L. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 21 33 (2002) 5088-5096
130. Thrower J.S., Hoffman L., Rechsteiner M., and Pickart C.M. Recognition of the polyubiquitin proteolytic signal. EMBO J. 19 1 (2000) 94-102
131. Trentin J.J., Yabe Y., and Taylor G. The quest for human cancer viruses. Science 137 (1962) 835-841
132. Trimble C.L., Hildesheim A., Brinton L.A., Shah K.V., and Kurman R.J. Heterogeneous etiology of squamous carcinoma of the vulva. Obstet. Gynecol. 87 1 (1996) 59-64
133. Tsai S.C., Pasumarthi K.B., Pajak L., Franklin M., Patton B., Wang H., Henzel W.J., Stults J.T., and Field L.J. Simian virus 40 large T antigen binds a novel Bcl-2 homology domain 3-containing proapoptosis protein in the cytoplasm. J. Biol. Chem. 275 5 (2000) 3239-3246
134. Wang J., Sampath A., Raychaudhuri P., and Bagchi S. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells. Oncogene 20 34 (2001) 4740-4749
135. Wazer D.E., Liu X.L., Chu Q., Gao Q., and Band V. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc. Natl. Acad. Sci. U. S. A. 92 9 (1995) 3687-3691
136. Welcker M., and Clurman B.E. The SV40 large T antigen contains a decoy phosphodegron that mediates its interactions with Fbw7/hCdc4. J. Biol. Chem. 280 9 (2005) 7654-7658
137. Welcker M., Orian A., Grim J.E., Eisenman R.N., and Clurman B.E. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr. Biol. 14 20 (2004) 1852-1857
138. Welcker M., Orian A., Jin J., Grim J.E., Harper J.W., Eisenman R.N., and Clurman B.E. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. U. S. A. 101 24 (2004) 9085-9090
139. Wu G., Lyapina S., Das I., Li J., Gurney M., Pauley A., Chui I., Deshaies R.J., and Kitajewski J. SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol. Cell. Biol. 21 21 (2001) 7403-7415
140. Yada M., Hatakeyama S., Kamura T., Nishiyama M., Tsunematsu R., Imaki H., Ishida N., Okumura F., Nakayama K., and Nakayama K.I. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 23 10 (2004) 2116-2125
141. Zhang B., Srirangam A., Potter D.A., and Roman A. HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes. Oncogene 24 15 (2005) 2585-2588